儿童过敏性哮喘：危险因素、诊断、控制与治疗
Paediatric Allergic Asthma: Risk Factors, Diagnosis, Control, and Treatment.
作者信息
Indolfi Cristiana, Klain Angela, Giudice Michele Miraglia Del, Tosca Maria Angela
机构信息
Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.
Allergy Center, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
出版信息
Children (Basel). 2025 May 30;12(6):713. doi: 10.3390/children12060713.
Abstract
This Special Issue, titled "Pediatric Allergic Asthma: Risk Factors, Diagnosis, Control, and Treatment", presents a comprehensive collection of articles that explore the complexities of asthma, which continues to impact millions of children around the world [...].
摘要
本期特刊名为“儿童过敏性哮喘：危险因素、诊断、控制与治疗”，呈现了一系列全面的文章，探讨了哮喘的复杂性，哮喘仍在影响着全球数百万儿童[...]。
相似文献
1
Paediatric Allergic Asthma: Risk Factors, Diagnosis, Control, and Treatment.儿童过敏性哮喘：危险因素、诊断、控制与治疗
Children (Basel). 2025 May 30;12(6):713. doi: 10.3390/children12060713.
2
Interventions for autumn exacerbations of asthma in children.儿童秋季哮喘加重的干预措施。
Cochrane Database Syst Rev. 2018 Mar 8;3(3):CD012393. doi: 10.1002/14651858.CD012393.pub2.
3
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.福莫特罗或沙美特罗常规用药对哮喘儿童的安全性：Cochrane系统评价综述
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD010005. doi: 10.1002/14651858.CD010005.pub2.
4
Asthma and Participation: A Scoping Review.哮喘与参与：一项范围综述
OTJR (Thorofare N J). 2025 Jul;45(3):360-369. doi: 10.1177/15394492241274754. Epub 2024 Aug 27.
5
Home telemonitoring and remote feedback between clinic visits for asthma.哮喘患者门诊就诊期间的家庭远程监测与远程反馈
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD011714. doi: 10.1002/14651858.CD011714.pub2.
6
A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma.一项系统性综述，旨在研究心理教育干预对患有难治性哮喘的成人和儿童的健康结局及成本的影响。
Health Technol Assess. 2005 Jun;9(23):iii-iv, 1-167. doi: 10.3310/hta9230.
7
Effectiveness of school-based family asthma educational programs in quality of life and asthma exacerbations in asthmatic children aged five to 18: a systematic review.基于学校的家庭哮喘教育项目对5至18岁哮喘儿童生活质量及哮喘发作的影响：一项系统评价
JBI Database System Rev Implement Rep. 2016 Nov;14(11):113-138. doi: 10.11124/JBISRIR-2016-003181.
8
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
9
Digital interventions to improve adherence to maintenance medication in asthma.数字干预措施以提高哮喘维持药物治疗的依从性。
Cochrane Database Syst Rev. 2022 Jun 13;6(6):CD013030. doi: 10.1002/14651858.CD013030.pub2.
10
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.儿童急性淋巴细胞白血病糖皮质激素治疗后下丘脑-垂体-肾上腺（HPA）轴抑制
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD008727. doi: 10.1002/14651858.CD008727.pub4.
本文引用的文献
1
Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group.学龄儿童重度哮喘：该年龄组生物学选择与挑战的最新评估
Children (Basel). 2025 Jan 29;12(2):167. doi: 10.3390/children12020167.
2
Intersocietal survey on real-world asthma management in Italian children.意大利儿童真实世界哮喘管理的多学会调查。
Ital J Pediatr. 2024 Aug 1;50(1):140. doi: 10.1186/s13052-024-01718-6.
3
Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.儿童哮喘监测建议：APAPARI、EAACI、INTERASMA、REG 和 WAO 认可的 PeARL 文件。
Pediatr Allergy Immunol. 2024 Apr;35(4):e14129. doi: 10.1111/pai.14129.
4
Safety and Tolerability of Omalizumab in Children with Allergic (-Mediated) Asthma: A Systematic Review and Meta-Analysis.奥马珠单抗治疗变应性（介导）哮喘儿童的安全性和耐受性：系统评价和荟萃分析。
Discov Med. 2023 Jun;35(176):233-241. doi: 10.24976/Discov.Med.202335176.24.
5
The prevalence and years lived with disability of asthma in children under 5 years old in Sichuan Southwest China, 1990-2019: A cross-sectional study.1990 - 2019年中国西南部四川省5岁以下儿童哮喘患病率及残疾生存年数：一项横断面研究
Front Pediatr. 2022 Aug 15;10:899519. doi: 10.3389/fped.2022.899519. eCollection 2022.
6
Paediatric asthma and non-allergic comorbidities: A review of current risk and proposed mechanisms.儿科哮喘与非过敏性共病：当前风险及提出的发病机制综述。
Clin Exp Allergy. 2022 Sep;52(9):1035-1047. doi: 10.1111/cea.14207. Epub 2022 Jul 28.
7
Diagnosis and management of asthma in children.儿童哮喘的诊断与管理。
BMJ Paediatr Open. 2022 Apr;6(1). doi: 10.1136/bmjpo-2021-001277.
8
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.度普利尤单抗治疗未控制的中重度哮喘患儿。
N Engl J Med. 2021 Dec 9;385(24):2230-2240. doi: 10.1056/NEJMoa2106567.
9
Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life.现实生活中T2低和T2高哮喘表型的特征分析
Biomedicines. 2021 Nov 13;9(11):1684. doi: 10.3390/biomedicines9111684.
10
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.特泽布尔单抗在成人和青少年重症、未控制哮喘中的应用。
N Engl J Med. 2021 May 13;384(19):1800-1809. doi: 10.1056/NEJMoa2034975.
Zotero 插件